Bringing the fundamentals into focus…
Back to Dianthus Therapeutics, Inc.
How Dianthus Therapeutics, Inc. stacks up
DNTH · against 244 other Healthcare companies of similar size
Profitability
5/ 100
Near the bottom of its peers.
Ranked #234 of 245 · scores higher than 4% of peers
Bars: peers in each 10-point band of the profitability score18 peers with a profitability score of 0–9, including DNTH · Click a bar to see the companies
Why profitability scores 5?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 99% of peers. Operating margin: -10699.6% vs peer median 7.1%
- a lower return on assets: weaker than 79% of peers. Return on assets: -15.8% vs peer median 1.7%
- a lower return on invested capital: weaker than 77% of peers. Return on invested capital: -16.2% vs peer median 4.7%
Metric by metric
Position: dot = DNTH, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | DNTH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 238 reported | -16.2% | 7.9% | 21% | 33% | |
| Operating marginHigher is better · 223 reported | -10699.6% | 10.9% | 1% | 33% | |
| Return on assetsHigher is better · 234 reported | -15.8% | 2.9% | 18% | 33% | |
| Return on equityHigher is better · 229 reported | -26.1% | 7.5% | 22% | Context only | |
| Gross marginHigher is better · 252 reported | 100.0% | 48.8% | 97% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around DNTH| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 3 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 3 | 3.8B USD | 99 | 71 | |
| 3 | 2.7B USD | 99 | 84 | |
| 232 | 2.4B USD | 7 | 20 | |
| 232 | 2.8B USD | 7 | 51 | |
| 234 | 5.7B USD | 5 | 52 | |
| 234 | 4.8B USD | 5 | 27 | |
| 234 | 4.6B USD | 5 | 29 | |
| 237 | 2.3B USD | 4 | 25 | |
| 237 | 3.8B USD | 4 | 48 | |
| 237 | 3.7B USD | 4 | 28 | |
| 240 | 3.1B USD | 3 | 27 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score